Value Bridge — ST. JOSEPHS MEDICAL CENTER
Current $42M → Target $58M (+$16.1M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$41.9M
Current EBITDA
$58.0M
Target EBITDA
+$16.1M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$3.6M
Payer Mix Optimization
$8.7M
Cost to Collect Reduction
$2.9M
Clean Claim Improvement
$2.2M
Volume & Rate Growth
$14.6M
What This Means
The 7-lever model projects a 38% EBITDA uplift from $42M to $58M. The highest-impact lever is Volume & Rate Growth at $5.8M probability-weighted.
IC talking point: "We see $16M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $177M in equity value creation."